CANACCORD GENUITY GRP INC by Canaccord Genuity Group, Inc. Financials - Benzinga

CANACCORD GENUITY GRP INC by Canaccord Genuity Group, Inc.

CCORFOTCPK

Trade with Public

Trade with Public

$9.57

-0.0285-0.3%

At close: Sep 18, 5:00 PM EST

Overview NewsFinancialsSentiment Compare

CANACCORD GENUITY GRP INC by Canaccord Genuity Group, Inc. Financials

CANACCORD GENUITY GRP INC by Canaccord Genuity Group, Inc. (CCORF) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Zynerba Pharmaceuticals R&D Expenses Reach $5.1M For Q1 2022, Here Are The Details

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), reported financial results for the first quarter ended March 31, 2022, revealing net loss of $8.5 million.

Vuk Zdinjak

Canaccord Financial Posts FQ4 Net Loss

Benzinga